Front Page › Patients & Testing
Medical patients, caregivers, home grow, laboratory results and product safety.
A formal petition submitted to Connecticut’s Department of Consumer Protection (DCP) is calling for greater transparency in cannabis safety testing, expanded access to laboratory results, and stronger independent oversight of medical cannabis products.
Cannabis consumers are not exactly famously known for driving into Connecticut to buy better cannabis….
Editor’s Note / Correction: Connecticut CannaTimes published an article on September 23 detailing Connecticut’s little-publicized state cannabis testing program at the Connecticut Agricultural Experiment Station, or CAES, and the state’s expansion into microbiological reference testing.
State records show Connecticut has operated a government cannabis testing program for years, tested more than 265 samples submitted by regulators, and planned its laboratory as an oversight operation for private cannabis labs. Now the state is adding microbiological testing for mold, Aspergillus and other pathogens using qPCR.
An affiliate of Connecticut CannaTimes has launched CannaScope Lite, a new beta tool designed to make Connecticut cannabis laboratory results easier for consumers to search and compare.
Connecticut cannabis consumers are routinely told two numbers: adults may possess 1.5 ounces of cannabis in public and up to 5 ounces in a locked container at home.
CT CannaTimes is seeking information from patients and consumers who may have purchased or consumed the cannabis flower product identified as 5EPU33-SC (Permanent Urkel). A review of laboratory records provided to CT CannaTimes shows what appears to be a significant discrepancy between two Certificates of Analysis (COAs) associated with the same product identifier.
CT CannaTimes is seeking information from Connecticut cannabis patients and consumers regarding a Brix Cannabis flower product identified during a review of Connecticut cannabis testing records.
For consumers with mold sensitivities, asthma, severe allergies, immunocompromising conditions, or other respiratory concerns.
***DISCLAIMER: This op-ed reflects the perspective of its contributor and does not necessarily represent the views of CT CannaTimes. We publish a range of voices to encourage open, honest discussion. ***
The 2025 Medical Cannabis Caregiver Bill HB 5429 came closer than most people realize to breaking through and passing to the house.
In 2025, Connecticut officials opposed expanding caregiver and patient cultivation under HB 5429 for one primary reason:
